Robert Lewis Harris serves as Executive at AMARANTUS BIOSCIENCE, INC., where they oversee executive responsibilities. Since joining the company, Robert Lewis Harris has executed 6 insider transactions totaling $14.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 2, 2015 involved purchasing 19,500 shares valued at $9.4K.
Robert Lewis Harris currently holds 96,070 shares of AMARANTUS BIOSCIENCE, INC. (AMBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Lewis Harris has been a net buyer of AMBS stock. They have purchased $14.5K and sold $0 worth of shares.
Robert Lewis Harris's most recent insider trade was on Dec 2, 2015, when they purchased 19,500 shares at $0.48 per share.
Get notified when new Form 4 filings are submitted
| $0.08 |
| Discretionary |
| Jan 14, 2013 | AMBS | $5.0K | Purchase | 50,000 | $0.10 | Discretionary |
| Nov 4, 2012 | AMBS | $0 | Award | 100,000 | $N/A | Discretionary |
| Jul 26, 2012 | AMBS | $140 | Purchase | 7,000 | $0.02 | Discretionary |
| Jul 15, 2012 | AMBS | $0 | Award | 31,250 | $N/A | Discretionary |